GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » Payments of Debt

Quest PharmaTech (TSXV:QPT) Payments of Debt : C$0.00 Mil (TTM As of Jul. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech Payments of Debt?

Quest PharmaTech's Payments of Debt for the three months ended in Jul. 2024 was C$0.00 Mil.

Quest PharmaTech's Payments of Debt for the trailing twelve months (TTM) ended in Jul. 2024 was C$0.00 Mil.


Quest PharmaTech Payments of Debt Historical Data

The historical data trend for Quest PharmaTech's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest PharmaTech Payments of Debt Chart

Quest PharmaTech Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -0.20

Quest PharmaTech Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Quest PharmaTech Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quest PharmaTech Payments of Debt Related Terms

Thank you for viewing the detailed overview of Quest PharmaTech's Payments of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Quest PharmaTech Business Description

Traded in Other Exchanges
N/A
Address
8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4
Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.
Executives
Ragupathy Madiyalakan Director
William John Meekison Director

Quest PharmaTech Headlines

No Headlines